{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T17:03:14Z","timestamp":1790787794637,"version":"4.1.0"},"reference-count":108,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","award":["ZS\/2023\/12\/182075"],"award-info":[{"award-number":["ZS\/2023\/12\/182075"]}],"id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["Na 292\/17-1"],"award-info":[{"award-number":["Na 292\/17-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["361210922"],"award-info":[{"award-number":["361210922"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["RTG 2408"],"award-info":[{"award-number":["RTG 2408"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Cancer"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.trecan.2025.01.014","type":"journal-article","created":{"date-parts":[[2025,2,20]],"date-time":"2025-02-20T17:02:14Z","timestamp":1740070934000},"page":"448-461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The enigma of maladaptation in gastric pathophysiology"],"prefix":"10.1016","volume":"11","author":[{"given":"Gunter","family":"Maubach","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun K.","family":"Kanthasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Gogia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8060-2313","authenticated-orcid":false,"given":"Michael","family":"Naumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.trecan.2025.01.014_bb0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1751-2980.2011.00550.x","article-title":"The gastric precancerous cascade","volume":"13","author":"Correa","year":"2012","journal-title":"J. Dig. Dis."},{"key":"10.1016\/j.trecan.2025.01.014_bb0010","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/apm.1965.64.1.31","article-title":"The two histological main types of gastric carcinoma: diffuse and so-called intestinal-type carcinoma","volume":"64","author":"Laur\u00e9n","year":"1965","journal-title":"Acta Pathol. Microbiol. Scand."},{"key":"10.1016\/j.trecan.2025.01.014_bb0015","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1038\/nature13480","article-title":"Comprehensive molecular characterization of gastric adenocarcinoma","volume":"513","author":"Bass","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.trecan.2025.01.014_bb0020","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.trecan.2025.01.014_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101404","article-title":"The current and future incidence and mortality of gastric cancer in 185 countries, 2020-40: a population-based modelling study","volume":"47","author":"Morgan","year":"2022","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.trecan.2025.01.014_bb0030","article-title":"Plasma metabolomic signatures of H. pylori infection, alcohol drinking, smoking, and risk of gastric cancer","author":"Yu","year":"2024","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.trecan.2025.01.014_bb0035","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1053\/j.gastro.2023.01.018","article-title":"Controlling gastric cancer in a world of heterogeneous risk","volume":"164","author":"Huang","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trecan.2025.01.014_bb0040","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/5584_2019_364","article-title":"The role of host genetic polymorphisms in Helicobacter pylori mediated disease outcome","volume":"11","author":"Clyne","year":"2019","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.trecan.2025.01.014_bb0045","article-title":"Host repair polymorphisms and H. pylori genes in gastric disease outcomes: who are the guardian and villains?","volume":"933","author":"de Oliveira","year":"2025","journal-title":"Gene"},{"key":"10.1016\/j.trecan.2025.01.014_bb0050","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1056\/NEJMoa2211807","article-title":"Helicobacter pylori, homologous-recombination genes, and gastric cancer","volume":"388","author":"Usui","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trecan.2025.01.014_bb0055","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2147\/IDR.S287631","article-title":"Heterogeneity of Helicobacter pylori strains isolated from patients with gastric disorders in Guiyang, China","volume":"14","author":"Mi","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"10.1016\/j.trecan.2025.01.014_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-62200-1","article-title":"Evidence of Helicobacter pylori heterogeneity in human stomachs by susceptibility testing and characterization of mutations in drug-resistant isolates","volume":"14","author":"Islam","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.trecan.2025.01.014_bb0065","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1038\/s41467-019-10050-1","article-title":"Within-host evolution of Helicobacter pylori shaped by niche-specific adaptation, intragastric migrations and selective sweeps","volume":"10","author":"Ailloud","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.01.014_bb0070","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.chom.2023.06.016","article-title":"A single-nucleotide polymorphism in Helicobacter pylori promotes gastric cancer development","volume":"31","author":"Sharafutdinov","year":"2023","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.trecan.2025.01.014_bb0075","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1053\/j.gastro.2023.12.022","article-title":"Global prevalence of Helicobacter pylori infection and incidence of gastric cancer between 1980 and 2022","volume":"166","author":"Chen","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.trecan.2025.01.014_bb0080","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJMra020542","article-title":"Helicobacter pylori Infection","volume":"347","author":"Suerbaum","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.trecan.2025.01.014_bb0085","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.chom.2024.02.012","article-title":"Longitudinal profiling of the microbiome at four body sites reveals core stability and individualized dynamics during health and disease","volume":"32","author":"Zhou","year":"2024","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.trecan.2025.01.014_bb0090","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41571-023-00747-0","article-title":"Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention","volume":"20","author":"Thrift","year":"2023","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.trecan.2025.01.014_bb0095","first-page":"1","article-title":"Schistosomes, liver flukes and Helicobacter pylori","volume":"61","author":"Anon.","year":"1994","journal-title":"IARC Monogr. Eval. Carcinog. Risks Hum."},{"key":"10.1016\/j.trecan.2025.01.014_bb0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102208","article-title":"Beyond the gastric epithelium \u2014 the paradox of Helicobacter pylori-induced immune responses","volume":"76","author":"Neuper","year":"2022","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.trecan.2025.01.014_bb0105","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007699","article-title":"Impact of Helicobacter pylori infection status on outcomes among patients with advanced gastric cancer treated with immune checkpoint inhibitors","volume":"11","author":"Magahis","year":"2023","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.trecan.2025.01.014_bb0110","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.999001","article-title":"Human gut microbiota in health and disease: unveiling the relationship","volume":"13","author":"Afzaal","year":"2022","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.trecan.2025.01.014_bb0115","article-title":"Role of the microbiome in the development and treatment of gastric cancer: an overview of the biological and clinical landscape","volume":"4","author":"Cella","year":"2024","journal-title":"ESMO Gastrointest. Oncol."},{"key":"10.1016\/j.trecan.2025.01.014_bb0120","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.3390\/antibiotics12091440","article-title":"Helicobacter pylori infections in children","volume":"12","author":"Nguyen","year":"2023","journal-title":"Antibiotics"},{"key":"10.1016\/j.trecan.2025.01.014_bb0125","article-title":"The effects of Helicobacter pylori infection on microbiota associated with gastric mucosa and immune factors in children","volume":"12","author":"Zheng","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2025.01.014_bb0130","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2197835","article-title":"Meta-analysis reveals Helicobacter pylori mutual exclusivity and reproducible gastric microbiome alterations during gastric carcinoma progression","volume":"15","author":"Li","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.trecan.2025.01.014_bb0135","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1038\/s41388-022-02377-9","article-title":"Meta-analysis of mucosal microbiota reveals universal microbial signatures and dysbiosis in gastric carcinogenesis","volume":"41","author":"Liu","year":"2022","journal-title":"Oncogene"},{"key":"10.1016\/j.trecan.2025.01.014_bb0140","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2186677","article-title":"Shotgun metagenomics of gastric biopsies reveals compositional and functional microbiome shifts in high- and low-gastric-cancer-risk populations from Colombia, South America","volume":"15","author":"Mannion","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.trecan.2025.01.014_bb0145","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1002\/2211-5463.13390","article-title":"Helicobacter pylori infection affects the human gastric microbiome, as revealed by metagenomic sequencing","volume":"12","author":"Wang","year":"2022","journal-title":"FEBS Open Bio"},{"key":"10.1016\/j.trecan.2025.01.014_bb0150","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12965","article-title":"Microbiome and function alterations in the gastric mucosa of asymptomatic patients with Helicobacter pylori infection","volume":"28","author":"Yu","year":"2023","journal-title":"Helicobacter"},{"key":"10.1016\/j.trecan.2025.01.014_bb0155","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000191","article-title":"Gastric microbiota in a low-Helicobacter pylori prevalence general population and their associations with gastric lesions","volume":"11","author":"Ndegwa","year":"2020","journal-title":"Clin. Transl. Gastroenterol."},{"key":"10.1016\/j.trecan.2025.01.014_bb0160","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1111\/jgh.15565","article-title":"Mucosal microbial microenvironment in early gastric neoplasia and non-neoplastic gastric disease","volume":"36","author":"Li","year":"2021","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.trecan.2025.01.014_bb0165","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000496102","article-title":"Mucosa-associated microbiota in the gastrointestinal tract of healthy Japanese subjects","volume":"101","author":"Kashiwagi","year":"2019","journal-title":"Digestion"},{"key":"10.1016\/j.trecan.2025.01.014_bb0170","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13099-021-00460-2","article-title":"Impact of Helicobacter pylori eradication on the gastric microbiome","volume":"13","author":"Mao","year":"2021","journal-title":"Gut Pathog."},{"key":"10.1016\/j.trecan.2025.01.014_bb0175","article-title":"dupA+ H. pylori reduces diversity of gastric microbiome and increases risk of erosive gastritis","volume":"13","author":"Chen","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.trecan.2025.01.014_bb0180","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12866-022-02594-y","article-title":"Analysis of gastric microbiome reveals three distinctive microbial communities associated with the occurrence of gastric cancer","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Microbiol."},{"key":"10.1016\/j.trecan.2025.01.014_bb0185","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s10120-022-01302-z","article-title":"Convergent dysbiosis of gastric mucosa and fluid microbiome during stomach carcinogenesis","volume":"25","author":"He","year":"2022","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.trecan.2025.01.014_bb0190","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12899","article-title":"Influences of Helicobacter pylori infection on diversity, heterogeneity, and composition of human gastric microbiomes across stages of gastric cancer development","volume":"27","author":"Xiao","year":"2022","journal-title":"Helicobacter"},{"key":"10.1016\/j.trecan.2025.01.014_bb0195","article-title":"Alterations of gastric microbiota in gastric cancer and precancerous stages","volume":"11","author":"Zhang","year":"2021","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.trecan.2025.01.014_bb0200","doi-asserted-by":"crossref","first-page":"48","DOI":"10.7150\/thno.65302","article-title":"Mucosal microbiome associates with progression to gastric cancer","volume":"27","author":"Png","year":"2022","journal-title":"Theranostics"},{"key":"10.1016\/j.trecan.2025.01.014_bb0205","article-title":"Gut microbiome alterations during gastric cancer: evidence assessment of case\u2013control studies","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.trecan.2025.01.014_bb0210","doi-asserted-by":"crossref","first-page":"997","DOI":"10.3389\/fmicb.2020.00997","article-title":"Changes of the gastric mucosal microbiome associated with histological stages of gastric carcinogenesis","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.trecan.2025.01.014_bb0215","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1038\/s41419-021-04396-y","article-title":"Interactions between gastric microbiota and metabolites in gastric cancer","volume":"12","author":"Dai","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.trecan.2025.01.014_bb0220","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/ijc.33848","article-title":"Oral and gastric microbiome in relation to gastric intestinal metaplasia","volume":"150","author":"Wu","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.trecan.2025.01.014_bb0225","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.3390\/cancers15215271","article-title":"Microbial-related metabolites may be involved in eight major biological processes and represent potential diagnostic markers in gastric cancer","volume":"15","author":"Nie","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.trecan.2025.01.014_bb0230","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01531-23","article-title":"Comparison of Helicobacter pylori positive and negative gastric cancer via multi-omics analysis","volume":"14","author":"Shang","year":"2023","journal-title":"mBio"},{"key":"10.1016\/j.trecan.2025.01.014_bb0235","article-title":"DNA damage repair and current therapeutic approaches in gastric cancer: a comprehensive review","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.trecan.2025.01.014_bb0240","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/s41698-024-00587-w","article-title":"Author correction: mutational signature-based identification of DNA repair deficient gastroesophageal adenocarcinomas for therapeutic targeting","volume":"8","author":"Prosz","year":"2024","journal-title":"NPJ Precis. Oncol."},{"key":"10.1016\/j.trecan.2025.01.014_bb0245","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jcmgh.2020.11.005","article-title":"Loss of RNF43 function contributes to gastric carcinogenesis by impairing DNA damage response","volume":"11","author":"Neumeyer","year":"2021","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.trecan.2025.01.014_bb0250","doi-asserted-by":"crossref","first-page":"13558","DOI":"10.18632\/aging.205329","article-title":"Lnc-PTCHD4-AS inhibits gastric cancer through MSH2-MSH6 dimerization and ATM-p53-p21 activation","volume":"15","author":"Wang","year":"2023","journal-title":"Aging"},{"key":"10.1016\/j.trecan.2025.01.014_bb0255","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1136\/gutjnl-2019-318640","article-title":"USF1 defect drives p53 degradation during Helicobacter pylori infection and accelerates gastric carcinogenesis","volume":"69","author":"Costa","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.trecan.2025.01.014_bb0260","doi-asserted-by":"crossref","first-page":"11082","DOI":"10.1074\/jbc.RA119.009981","article-title":"Helicobacter pylori infection downregulates the DNA glycosylase NEIL2, resulting in increased genome damage and inflammation in gastric epithelial cells","volume":"295","author":"Sayed","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.trecan.2025.01.014_bb0265","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.trecan.2025.01.014_bb0270","doi-asserted-by":"crossref","DOI":"10.1093\/femspd\/ftac025","article-title":"Tumor necrosis factor-\u03b1-inducing protein of Helicobacter pylori promotes epithelial-mesenchymal transition and cancer stem-like cells properties via activation of Wnt\/\u03b2-catenin signaling pathway in gastric cancer cells","volume":"80","author":"Guo","year":"2022","journal-title":"Pathog. Dis."},{"key":"10.1016\/j.trecan.2025.01.014_bb0275","article-title":"Enhanced LRP8 expression induced by Helicobacter pylori drives gastric cancer progression by facilitating \u03b2-Catenin nuclear translocation","author":"Liu","year":"2024","journal-title":"J. Adv. Res."},{"key":"10.1016\/j.trecan.2025.01.014_bb0280","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/s41416-022-01747-0","article-title":"CCT5 induces epithelial-mesenchymal transition to promote gastric cancer lymph node metastasis by activating the Wnt\/\u03b2-catenin signalling pathway","volume":"126","author":"Li","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.trecan.2025.01.014_bb0285","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1158\/1541-7786.MCR-20-0180","article-title":"Wnt\/b-Catenin signaling axis is required for TFEB-mediated gastric cancer metastasis and epithelial-mesenchymal transition","volume":"18","author":"Li","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.trecan.2025.01.014_bb0290","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.devcel.2019.06.003","article-title":"The Hippo signaling pathway in development and disease","volume":"50","author":"Zheng","year":"2019","journal-title":"Dev. Cell"},{"key":"10.1016\/j.trecan.2025.01.014_bb0295","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41419-023-05568-8","article-title":"Hippo pathway dysregulation in gastric cancer: from Helicobacter pylori infection to tumor promotion and progression","volume":"14","author":"Messina","year":"2023","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.trecan.2025.01.014_bb0300","doi-asserted-by":"crossref","DOI":"10.1172\/JCI174587","article-title":"The alanyl\u2013tRNA synthetase AARS1 moonlights as a lactyltransferase to promote YAP signaling in gastric cancer","volume":"134","author":"Ju","year":"2024","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.trecan.2025.01.014_bb0305","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00018-024-05178-3","article-title":"YAP1\u2013CPNE3 positive feedback pathway promotes gastric cancer cell progression","volume":"81","author":"Li","year":"2024","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.trecan.2025.01.014_bb0310","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1186\/s13046-023-02870-3","article-title":"Regulation of the Hippo\/YAP axis by CXCR7 in the tumorigenesis of gastric cancer","volume":"42","author":"Wang","year":"2023","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.trecan.2025.01.014_bb0315","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41420-022-00868-y","article-title":"The E3 ubiquitin ligase, FBXW5, promotes the migration and invasion of gastric cancer through the dysregulation of the Hippo pathway","volume":"8","author":"Yao","year":"2022","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.trecan.2025.01.014_bb0320","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12964-023-01050-2","article-title":"WWP2 drives the progression of gastric cancer by facilitating the ubiquitination and degradation of LATS1 protein","volume":"21","author":"Zou","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.trecan.2025.01.014_bb0325","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jcmgh.2019.10.007","article-title":"The Hippo kinase LATS2 controls Helicobacter pylori-induced epithelial-mesenchymal transition and intestinal metaplasia in gastric mucosa","volume":"9","author":"Molina-Castro","year":"2020","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"key":"10.1016\/j.trecan.2025.01.014_bb0330","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2192501","article-title":"YAP and \u03b2-catenin cooperate to drive H. pylori-induced gastric tumorigenesis","volume":"15","author":"Li","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.trecan.2025.01.014_bb0335","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1038\/s12276-023-01013-0","article-title":"Cancer-associated fibroblasts: from basic science to anticancer therapy","volume":"55","author":"Yang","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.trecan.2025.01.014_bb0340","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1038\/s41388-020-1197-4","article-title":"Cancer-associated fibroblasts-derived VCAM1 induced by H. pylori infection facilitates tumor invasion in gastric cancer","volume":"39","author":"Shen","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.trecan.2025.01.014_bb0345","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1158\/0008-5472.CAN-20-2756","article-title":"Cancer-associated fibroblasts promote aggressive gastric cancer phenotypes via heat shock factor 1-mediated secretion of extracellular vesicles","volume":"81","author":"Grunberg","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.trecan.2025.01.014_bb0350","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.micres.2018.09.011","article-title":"Helicobacter pylori evasion strategies of the host innate and adaptive immune responses to survive and develop gastrointestinal diseases","volume":"218","author":"Karkhah","year":"2019","journal-title":"Microbiol. Res."},{"key":"10.1016\/j.trecan.2025.01.014_bb0355","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.trecan.2024.03.008","article-title":"Gastric cancer immunosuppressive microenvironment heterogeneity: implications for therapy development","volume":"10","author":"Yasuda","year":"2024","journal-title":"Trends Cancer"},{"key":"10.1016\/j.trecan.2025.01.014_bb0360","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2105102","article-title":"Helicobacter pylori actively suppresses innate immune nucleic acid receptors","volume":"14","author":"Dooyema","year":"2022","journal-title":"Gut Microbes"},{"key":"10.1016\/j.trecan.2025.01.014_bb0365","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3390\/jpm14070736","article-title":"The cGAS\/STING pathway\u2014a new potential biotherapeutic target for gastric cancer?","volume":"14","author":"Tian","year":"2024","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.trecan.2025.01.014_bb0370","article-title":"Clinical applications of STING agonists in cancer immunotherapy: current progress and future prospects","volume":"15","author":"Wang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2025.01.014_bb0375","article-title":"Decreased expression of STING predicts poor prognosis in patients with gastric cancer","volume":"7","author":"Song","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.trecan.2025.01.014_bb0380","article-title":"Enhancing immunotherapy outcomes by targeted remodeling of the tumor microenvironment via combined cGAS\u2013STING pathway strategies","volume":"15","author":"Huang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2025.01.014_bb0385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010326","article-title":"Helicobacter pylori binds human annexins via lipopolysaccharide to interfere with Toll-like receptor 4 signaling","volume":"18","author":"Schmidinger","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.trecan.2025.01.014_bb0390","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1282680","article-title":"Immune evasion by proteolytic shedding of natural killer group 2, member D ligands in Helicobacter pylori infection","volume":"15","author":"Anthofer","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.trecan.2025.01.014_bb0395","doi-asserted-by":"crossref","DOI":"10.1111\/hel.13069","article-title":"Helicobacter pylori enhances HLA-C expression in the human gastric adenocarcinoma cells AGS and can protect them from the cytotoxicity of natural killer cells","volume":"29","author":"Apoorva","year":"2024","journal-title":"Helicobacter"},{"key":"10.1016\/j.trecan.2025.01.014_bb0400","doi-asserted-by":"crossref","DOI":"10.1111\/hel.12813","article-title":"Helicobacter pylori induces gastric cancer via down-regulating miR-375 to inhibit dendritic cell maturation","volume":"26","author":"Zhang","year":"2021","journal-title":"Helicobacter"},{"key":"10.1016\/j.trecan.2025.01.014_bb0405","doi-asserted-by":"crossref","first-page":"8547","DOI":"10.2147\/OTT.S251625","article-title":"LncRNA SNHG15 contributes to immuno-escape of gastric cancer through targeting miR141\/PD-L1","volume":"13","author":"Dang","year":"2020","journal-title":"Onco. Targets Ther."},{"key":"10.1016\/j.trecan.2025.01.014_bb0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2020.112315","article-title":"Tumor-associated macrophages induce PD-L1 expression in gastric cancer cells through IL-6 and TNF-\u03b1 signaling","volume":"396","author":"Ju","year":"2020","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.trecan.2025.01.014_bb0415","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.4049\/jimmunol.1900753","article-title":"Proinflammatory S100A8 induces PD-L1 expression in macrophages, mediating tumor immune escape","volume":"204","author":"Li","year":"2020","journal-title":"J. Immun."},{"key":"10.1016\/j.trecan.2025.01.014_bb0420","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41389-020-00249-z","article-title":"CXCL5 promotes gastric cancer metastasis by inducing epithelial\u2013mesenchymal transition and activating neutrophils","volume":"9","author":"Mao","year":"2020","journal-title":"Oncogenesis"},{"key":"10.1016\/j.trecan.2025.01.014_bb0425","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1111\/cas.14896","article-title":"H19 promotes aerobic glycolysis, proliferation, and immune escape of gastric cancer cells through the microRNA-519d-3p\/lactate dehydrogenase A axis","volume":"112","author":"Sun","year":"2021","journal-title":"Cancer Sci."},{"key":"10.1016\/j.trecan.2025.01.014_bb0430","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.18632\/aging.102764","article-title":"Notch1\/2\/3\/4 are prognostic biomarker and correlated with immune infiltrates in gastric cancer","volume":"12","author":"Hu","year":"2020","journal-title":"Aging"},{"key":"10.1016\/j.trecan.2025.01.014_bb0435","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","article-title":"Gastric cancer treatment: recent progress and future perspectives","volume":"16","author":"Guan","year":"2023","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.trecan.2025.01.014_bb0440","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2022.40.16_suppl.TPS4164","article-title":"Trial in progress: Phase 3 study of bemarituzumab + mFOLFOX6 versus placebo + mFOLFOX6 in previously untreated advanced gastric or gastroesophageal junction (GEJ) cancer with FGFR2b overexpression (FORTITUDE-101)","volume":"40","author":"Smyth","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.trecan.2025.01.014_bb0445","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/S0140-6736(23)00620-7","article-title":"Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial","volume":"401","author":"Shitara","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.trecan.2025.01.014_bb0450","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1200\/JCO.22.00686","article-title":"Neoadjuvant nivolumab plus ipilimumab and adjuvant nivolumab in localized deficient mismatch repair\/microsatellite instability-high gastric or esophagogastric junction adenocarcinoma: the GERCOR NEONIPIGA Phase II Study","volume":"41","author":"Andr\u00e9","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.trecan.2025.01.014_bb0455","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1200\/JCO.2023.41.4_suppl.358","article-title":"INFINITY: a multicentre, single-arm, multi-cohort, phase II trial of tremelimumab and durvalumab as neoadjuvant treatment of patients with microsatellite instability-high (MSI) resectable gastric or gastroesophageal junction adenocarcinoma (GAC\/GEJAC)","volume":"41","author":"Pietrantonio","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.trecan.2025.01.014_bb0460","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/S1470-2045(23)00515-6","article-title":"Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial","volume":"24","author":"Rha","year":"2023","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.trecan.2025.01.014_bb0465","doi-asserted-by":"crossref","first-page":"6586","DOI":"10.3390\/ijms21186586","article-title":"The crosstalk between microbiome and immune response in gastric cancer","volume":"21","author":"Nasr","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.trecan.2025.01.014_bb0470","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1186\/s12885-022-10004-9","article-title":"Association of Helicobacter pylori infection with survival outcomes in advanced gastric cancer patients treated with immune checkpoint inhibitors","volume":"22","author":"Che","year":"2022","journal-title":"BMC Cancer"},{"key":"10.1016\/j.trecan.2025.01.014_bb0475","article-title":"Helicobacter pylori and immunotherapy for gastrointestinal cancer","volume":"5","author":"Jia","year":"2024","journal-title":"Innovation"},{"key":"10.1016\/j.trecan.2025.01.014_bb0480","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010354","article-title":"Impact of Helicobacter pylori on immunotherapy in gastric cancer","volume":"12","author":"Li","year":"2024","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.trecan.2025.01.014_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.bj.2024.100698","article-title":"Gut microbiota and clinical response to immune checkpoint inhibitor therapy in patients with advanced cancer","volume":"47","author":"Chang","year":"2024","journal-title":"Biomed. J."},{"key":"10.1016\/j.trecan.2025.01.014_bb0490","doi-asserted-by":"crossref","DOI":"10.1016\/j.bpg.2024.101944","article-title":"The role of the gut microbiome in regulating the response to immune checkpoint inhibitor therapy","volume":"72","author":"Dean","year":"2024","journal-title":"Best Pract. Res. Clin. Gastroenterol."},{"key":"10.1016\/j.trecan.2025.01.014_bb0495","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12935-022-02471-8","article-title":"Antitumor responses in gastric cancer by targeting B7H3 via chimeric antigen receptor T cells","volume":"22","author":"Sun","year":"2022","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.trecan.2025.01.014_bb0500","doi-asserted-by":"crossref","first-page":"3850","DOI":"10.7150\/ijbs.64630","article-title":"Development of mesothelin-specific CAR NK-92 cells for the treatment of gastric cancer","volume":"17","author":"Cao","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.trecan.2025.01.014_bb0505","doi-asserted-by":"crossref","DOI":"10.1002\/2056-4538.70002","article-title":"Challenges for pathologists in implementing clinical microbiome diagnostic testing","volume":"10","author":"Gerasimova","year":"2024","journal-title":"J. Pathol. Clin. Res."},{"key":"10.1016\/j.trecan.2025.01.014_bb0510","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1158\/2159-8290.CD-19-0442","article-title":"Tumor genomic profiling guides patients with metastatic gastric cancer to targeted treatment: The VIKTORY Umbrella Trial","volume":"9","author":"Lee","year":"2019","journal-title":"Cancer Discov."},{"key":"10.1016\/j.trecan.2025.01.014_bb0515","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s13238-020-00724-8","article-title":"A practical guide to amplicon and metagenomic analysis of microbiome data","volume":"12","author":"Liu","year":"2021","journal-title":"Protein Cell"},{"key":"10.1016\/j.trecan.2025.01.014_bb0520","doi-asserted-by":"crossref","DOI":"10.1172\/JCI154944","article-title":"Next-generation sequencing: insights to advance clinical investigations of the microbiome","volume":"132","author":"Wensel","year":"2022","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.trecan.2025.01.014_bb0525","doi-asserted-by":"crossref","first-page":"7024","DOI":"10.1038\/s41598-024-57670-2","article-title":"Comparison of the effectiveness of different normalization methods for metagenomic cross-study phenotype prediction under heterogeneity","volume":"14","author":"Wang","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.trecan.2025.01.014_bb0530","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1038\/s41467-022-28034-z","article-title":"Microbiome differential abundance methods produce different results across 38 datasets","volume":"13","author":"Nearing","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.trecan.2025.01.014_bb0535","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ymeth.2023.12.007","article-title":"Microbiome metabolite quantification methods enabling insights into human health and disease","volume":"222","author":"Roach","year":"2024","journal-title":"Methods"},{"key":"10.1016\/j.trecan.2025.01.014_bb0540","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/s43588-022-00247-8","article-title":"Large-scale microbiome data integration enables robust biomarker identification","volume":"2","author":"Xiao","year":"2022","journal-title":"Nat. Comput. Sci."}],"container-title":["Trends in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803325000408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405803325000408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T21:54:41Z","timestamp":1778882081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405803325000408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":108,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2405803325000408"],"URL":"https:\/\/doi.org\/10.1016\/j.trecan.2025.01.014","relation":{},"ISSN":["2405-8033"],"issn-type":[{"value":"2405-8033","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The enigma of maladaptation in gastric pathophysiology","name":"articletitle","label":"Article Title"},{"value":"Trends in Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trecan.2025.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}